Lennart Holm

A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose

Fumihiko Takeuchi, Ralph McGinnis, Stéphane Bourgeois et al. · PLoS Genetics · 2009 · 640 citations · Full text

Medicine, Molecular Genetics, Pharmacology +13

The largest prospective warfarin-treated cohort supports genetic forecasting

Mia Wadelius, Leslie Y. Chen, Jonatan D. Lindh et al. · Blood · 2008 · 552 citations · Full text

Life Sciences, Genetics, Pharmacology +4

Incidence and predictors of severe bleeding during warfarin treatment

Jonatan D. Lindh, Lennart Holm, Marja­‐Liisa Dahl et al. · Journal of Thrombosis and Thrombolysis · 2007 · 75 citations

Medicine, Internal Medicine, Pharmacotherapy +10

Influence of age, sex and seriousness on reporting of adverse drug reactions in Sweden

Lennart Holm, Elisabet Ekman, Kerstin Jorsäter Blomgren · Pharmacoepidemiology and Drug Safety · 2017 · 68 citations

Pharmacy, Pharmacology, Clinical Pharmacology +16

Adverse Drug Reactions in a Tertiary Care Emergency Medicine Ward - Prevalence, Preventability and Reporting

Diana M. Rydberg, Lennart Holm, Ida Engqvist et al. · PLoS ONE · 2016 · 38 citations · Full text

Pharmacy, Emergency Medicine, Internal Medicine +17